Announcements Trials

Browse Landscape

Status

Withdrawn 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Bone Neoplasms 1

Interventions

Fluorouracil 11 Leucovorin 10 Oxaliplatin 9 Bevacizumab 6 Irinotecan 5 Capecitabine 3 regorafenib 2 aflibercept 2 Folfox protocol 2 Exercise 2 Chemotherapy, Adjuvant 2 Cetuximab 2 Biopsy 2 Atorvastatin 2 tucatinib 1 trifluridine tipiracil drug combination 1 trastuzumab biosimilar HLX02 1 sulindac sulfone 1 sargramostim 1 retrovector encoding mutant anti-cyclin G1 1 poly ICLC 1 pidilizumab 1 pembrolizumab 1 p53 peptide 264-272, human 1 nilotinib 1 monalizumab 1 lonafarnib 1 irofulven 1 infigratinib 1 grp protein, Drosophila 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Colonic Neoplasms × Anesthesia, Epidural × Clear all

NCT03974984 2020-11-05

ANIMOX

University of Copenhagen

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡